Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Novel transcript, antisense to SHROOM2" (ENSG00000304844) is an RNA gene that is transcribed in the antisense direction to the SHROOM2 protein-coding gene. Antisense transcripts are a type of natural non-coding RNA that can regulate the expression of their overlapping sense gene through mechanisms such as RNA masking, modulation of splicing, and influencing chromatin architecture[3][7]. There is currently no evidence that this transcript encodes a protein, has a direct pharmacological role, or serves as a recognized therapeutic target. At present, its biological characterization is limited, with no established disease association, pharmacological interactions, or biomarker use. It is primarily of interest as an example of antisense transcription in genomic regulation, rather than as a direct clinical or drug development target[9][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to SHROOM2 (ENSG00000304844).